Having shown that AdIL-17A transduction in 4T1 cells induces both immune activation and MDSC-mediated immune suppression, we hypothesized that IL-17A-activated CD4 and CD8 T cells would exert anti-tumor effects if MDSCs were depleted. Here, IL17A is linked to neoplasm.